Correlation Between Regenxbio and Recursion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Regenxbio and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regenxbio and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Regenxbio and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Recursion Pharmaceuticals.

Diversification Opportunities for Regenxbio and Recursion Pharmaceuticals

-0.12

Correlation Coefficient

Regenxbio  Recursion Pharmaceuticals

Good diversification

The 3 months correlation between Regenxbio and Recursion is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Regenxbio i.e., Regenxbio and Recursion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Regenxbio and Recursion Pharmaceuticals

Given the investment horizon of 90 days Regenxbio is expected to under-perform the Recursion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.64 times less risky than Recursion Pharmaceuticals. The stock trades about -0.08 of its potential returns per unit of risk. The Recursion Pharmaceuticals is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  627.00  in Recursion Pharmaceuticals on November 19, 2024 and sell it today you would earn a total of  426.00  from holding Recursion Pharmaceuticals or generate 67.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Regenxbio  vs.  Recursion Pharmaceuticals

Regenxbio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Regenxbio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Recursion Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Regenxbio and Recursion Pharmaceuticals

The main advantage of trading using opposite Regenxbio and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.

The idea behind Regenxbio and Recursion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.